Genistein was found to inhibit the growth of colorectal cancer stem cells in an animal model of carcinogenesis induced with dimethyl hydrazine, through the down-regulation of CD133/CD44 and the inhibition of the Wnt/β-catenin signaling pathway [144]. This evidence concerns the gene CD44 and colorectal cancer.